SLC5A5 and carcinoma: In summary, the absence of BRAF and NRAS mutations in every carcinoma displaying NIS membrane staining at immunohistochemistry supports the assumption that the genetic background of tumors may be of major importance to SLC5A5 expression as well as to NIS targeting to the basolateral membrane.